Symbiotic-GYN-18 (GOG-3145/ENGOT-EN37/APGOT-EN6/LACOG 0426-EVA): A Phase 3 study of PF-08634404, a PD-1/VEGF bispecific antibody, plus chemotherapy in patients with advanced or recurrent mismatch repair proficient endometrial cancer (ESMO Asia 2026) - Oct 1, 2026 - Abstract #527TiP; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available
Bispecific • Clinical • Metastases • Mismatch repair • P3 data • pMMR • Endometrial Cancer • Oncology • Solid Tumor
|
|
Jung-Yun Lee; Yoland Antill; Fernanda C. Casarotto; Ramez N. Eskander; Kosei Hasegawa; Thomas J. Herzog; Brian M. Slomovitz; David SP Tan; Xiaohua Wu; Ewa Kalinka; Michalis Liontos; Ibrahim Yalcin; Xia Tao; Matko Kalac; Stella Lin; Philipp Harter; Kathleen N. Moore
|